Ranbaxy trying to make inroads in herbal drugs market

by Medindia Content Team on  March 22, 2003 at 12:00 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Ranbaxy trying to make inroads in herbal drugs market
Ranbaxy Laboratories Chairman, Tajendra Khanna, in a recent seminar organised by Guru Gobind Singh Indraprastha University on 'Managing Corporate Reputation', spoke about the comapny's plan of foraying into the herbal drugs market. He said that their products would create stiff competition for the key player in the market - Dabur, which has 60 per cent market share. The company plans to market a few herbal drugs in the forthcoming months, whose details are available in their corporate website. The company's products have already shown remarkable progress in the US market where the sales has increased from $15 million in 1998 to $296 million in 2002 and, the figures are pegged at $400 million for this year. The worldwide sales for the herbal drugs this year is expected to be around $930 million, while the company's Indian operations predict sales at around $190 million.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Saint Johns Wort Signature Drug Toxicity High Blood Pressure and Herbs Drugs Banned in India Acai Berry - Does It Really Work? Home Grown Herbs for Holistic Nutrition 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive